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ARTICLE
Performance of fixed-pressure valve with 
antisiphon device SPHERA® in hydrocephalus 
treatment and overdrainage prevention
Desempenho da válvula de pressão fixa com antissifão SPHERA® no tratamento da 
hidrocefalia e na prevenção da ocorrência de hiperdrenagem
Fernando Campos Gomes Pinto1, Renan Muralho Pereira2, Felippe Saad1, Manoel Jacobsen Teixeira1
Surgical treatment of hydrocephalus in adults is attained 
through the implantation of ventricular shunt (VS) systems, 
neuroendoscopy or through the association of both procedures, 
offering the possibility of significant neurological improvement1.
The United Kingdom Shunt Registry showed in 13,206 
adults with hydrocephalus submitted to VS implant that 22% 
of patients required reoperation within five years2.
Patients with hydrocephalus and risk factors for over-
drainage may be submitted to VS implant with antisiphon 
device. This valve-integrated device allows the patient, 
while in the orthostatic position, to increase the resis-
tance to drainage of cerebrospinal fluid (CSF), reducing 
the siphoning effect that always occurs, thus avoiding 
overdrainage2-6.
The objective of this study was to prospectively evaluate for 
two years the clinical performance of fixed-pressure valve with 
SPHERA® antisiphon device in the treatment of 35 adult patients, 
with hydrocephalus and high clinical susceptibility to overdrainage.
METHODS
After approval by the Ethics Committee, all patients ad-
mitted to the Cerebral Hydrodynamics Group, Division of 
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ABSTRACT
Patients with hydrocephalus and risk factors for overdrainage may be submitted to ventricular shunt (VS) implant with antisiphon device. 
The objective of this study was to prospectively evaluate for two years the clinical and tomographic results of the implant of fixed-pressure 
valves with antisiphon device SPHERA® in 35 adult patients, with hydrocephalus and risk factors for overdrainage. Of these, 3 had congenital 
hydrocephalus in adult patients with very dilated ventricles (Evans index >50%), 3 had symptomatic overdrainage after previous VS implant 
(subdural hematoma, hygroma or slit ventricle syndrome), 1 had previous chronic subdural hematoma, 15 had normal pressure hydrocepha-
lus with final lumbar pressure <5 cm H2O after tap test (40 mL), 6 had pseudotumor cerebri, and 7 had hydrocephalus due to other causes. 
Clinical improvement was observed and sustained in 94.3% of the patients during the two-year period with no computed tomography (CT) 
evidence of hypo or overdrainage, and no immediate early or late significant complications.
Key words: hydrocephalus, pseudotumor cerebri, cerebrospinal fluid shunts.
RESUMO
Pacientes com hidrocefalia e fatores de risco para hiperdrenagem podem ser submetidos ao implante de derivação ventricular (VS) com 
mecanismo antissifão. O objetivo deste trabalho foi avaliar prospectivamente os resultados clínicos e tomográficos do implante de válvulas 
de pressão fixa com antissifão SPHERA® em 35 pacientes adultos, com hidrocefalia e risco de hiperdrenagem, acompanhados por dois anos. 
Destes, 3 apresentavam hidrocefalia congênita em adulto, com ventrículos muito dilatados (índice de Evans >50%); 3 tinham hiperdrenagem 
sintomática pós-derivação ventricular prévia (hematoma subdural, higroma ou síndrome dos ventrículos colabados; 1 apresentava hemato-
ma subdural crônico pregresso; 15 apresentavam hidrocefalia de pressão normal com pressão lombar final <5 cm H2O após tap test (40 mL); 
6 apresentavam pseudotumor cerebral; e 7, devido a outras causas. A melhoria clínica foi detectada e sustentada em 94,3% dos pacientes no 
período de dois anos, sem indícios tomográficos de hipo ou hiperdrenagem e sem complicações significativas imediatas, precoces ou tardias.
Palavras-Chave: hidrocefalia, pseudotumor cerebral, derivações do líquido céfalorraquidiano.
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Functional Neurosurgery of the Institute of Psychiatry, at 
Hospital das Clínicas, Faculty of Medicine, University of São 
Paulo (HC-FMUSP), from January 1st, 2009 to January 1st, 
2010, with hydrocephalus and high risk for overdrainage, 
as the previously established inclusion criteria, were select-
ed for the implant of a fixed-pressure valve, with antisiphon 
membrane mechanism (SPHERA®, HPBIO, São Paulo, Brazil) 
and clinical-radiological follow-up up to January 1st, in 2012.
The SPHERA® valve works through a coil spring mecha-
nism, seat and ruby sphere. According to the characteristic 
of the spring, four strips of pressure difference ensure a flow 
of 21 mL/h, which corresponds to the physiological CSF pro-
duction: extralow (1 to 3 cm H2O), low (3 to 7 cm H2O), me-
dium (7 to 11 cm H2O), and high (11 to 14 cm H2O).
The body of the prosthesis measures 42 x 14 x 6.5 mm. Its 
proximal portion contains the valve mechanism, the central 
part is a chamber for digital pumping or puncture, and its 
distal part contains the antisiphon membrane mechanism 
(Fig 1). When the pressure distal to the antisiphon mecha-
nism becomes negative, the membrane temporarily occludes 
the system, avoiding overdrainage. This occurs when the pa-
tient is in the orthostatic position (up to – 50 cm H2O) or ad-
ditionally during inspiration in patients with ventriculopleu-
ral shunt (up to – 8 cm H2O), as seen in Fig 2.
Inclusion criteria included patient with more than 16 
years of age; and some clinical and radiological conditions 
considered to have high risk for overdrainage by VS: con-
genital hydrocephalus in adults with very dilated ventricles 
(Evans index >50%); previous symptomatic overdrainage 
post-VS (subdural hematoma, hygroma or slit ventricle syn-
drome); previous chronic subdural hematoma (not related to 
VS); normal pressure hydrocephalus (NPH) with final lumbar 
pressure <5 cm H2O after tap test (40 mL); and pseudotumor 
cerebri with VS indication.
Patients were evaluated for two years after surgery, 
through preestablished routine outpatient appointments 
with the Cerebral Hydrodynamics Group of HC-FMUSP: ten 
days after surgery for stitch removal, three months (cranial 
computed tomography scan – CT – requested), six months, 
one year and two years after surgery. The evaluation criteria 
of the patients were:
· clinical: comparison of pre and postoperative neurologi-
cal assessment; postoperative infection; signs and symp-
toms of overdrainage or system malfunction (headache, 
postural headache, nausea, vomiting, visual alterations, 
altered level of consciousness);
· radiological: pre and postoperative CT, immediately af-
ter surgery and after three months (size of the ventricles, 
deviations of deep brain structures, patency and size of 
cisterns and cortical sulci, proximal catheter placement, 
subdural collections or hygroma).
Fig 1. Illustrative picture of the SPHERA® valve: spring coil 
mechanism, seat and ruby sphere; chamber for digital pumping 
or puncture and membrane-type antisiphon mechanism (when 
the pressure distal to the antisiphon mechanism becomes 
negative, the membrane temporarily occludes).
Fig 2. Pressure versus flow, SPHERA® valve (extralow, low, medium, and high pressure) in the horizontal and vertical positions.
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RESULTS
The study included 35 patients, 21 men and 14 women. The 
age ranged from 16 to 86 years-old, with a mean of 51 years-old.
Table shows the distribution of procedures by the hy-
drocephalus etiology and pressure valve used, indicat-
ing that two patients underwent ventriculopleural shunt 
(VPS) and that three had symptomatic overdrainage after 
previous derivation.
Clinical assessment
After 24 months of follow-up, 33 patients showed clin-
ical improvement (33/35=94.3%). A patient with hydro-
cephalus after traumatic brain injury by gunshot wound 
showed no alteration at the neurological assessment, 
and one with normal hydrocephalus pressure initial-
ly improved for one year, but showed a slight worsening 
in gait after two years of follow-up. In these two patients 
(2/35=5.7%), the valve worked normally at digital compres-
sion of the pumping chamber and there was a decrease in 
ventricular dimensions with no evidence of overdrainage 
(subdural collections).
Patients with pseudotumor cerebri showed improve-
ment in headache, sight, and resolution of papilledema three 
months after surgery.
No patient had postural headache, nausea, vomiting or 
other signs of intracranial hypertension or hypotension dur-
ing the two-year follow-up.
One patient with congenital hydrocephalus, who had un-
dergone five previous derivations, the latter being the im-
plant of the low-pressure SPHERA® valve, showed postop-
erative ventriculitis; he was submitted to system removal, 
intravenous antibiotic therapy for 21 days and reimplanta-
tion of a new SPHERA® system and showed improvement at 
the neurological assessment.
The two patients submitted to VPS showed improvement 
and had no complications.
Radiological assessment
The patients showed a reduction in ventricular size and 
no patient had subdural collections or hygroma.
The three patients who already had another valve and un-
derwent surgery to treat the overdrainage condition showed 
an increase in ventricular dimensions and reduction of sub-
dural collections associated with clinical improvement. Fig 3 
shows the preoperative CT of one of these patients and the 
control CT three months after valve replacement. The resolu-
tion of bilateral subdural collection and ventricular increase 
was associated with improvement in postural headache, 
with no signs or symptoms of intracranial hypertension.
In patients who underwent brain magnetic resonance 
imaging (MRI) for reasons other than hydrocephalus control, 
it was observed that the tested valve did not produce arti-
facts in image acquisition.
Fig 3. Patient with thalamic arteriovenous malformation to 
the right, and slit ventricle syndrome after prior ventricular 
shunt for three months with medium pressure PS Medical® 
valve (Medtronic). (A) Computed tomography without contrast, 
axial view, showing preoperative status: collapsed ventricles, 
bilateral subdural collections, and thalamic arteriovenous 
malformation to the right. (B) Computed tomography 
without contrast, axial view, three months after medium-
pressure SPHERA® valve replacement: increased ventricular 
dimensions and resolution of bilateral collections.
A B
Table. Etiology of cerebral hydrodynamic disease, number of cases, and valve pressure. Almost all patients underwent 
ventriculoperitoneal shunt, except two with congenital hydrocephalus. These patients underwent ventricular shunt to pleura as it 
was not possible to use the peritoneum as the distal place (previously treated peritonitis) and the atrium was tried before, without 
success. Three patients had ventriculoperitoneal shunt and hyperdrainage, one case with pseudotumor cerebri had slit ventricle 
syndrome, one normal pressure hydrocephalus had chronic subdural hematoma, and one patient with thalamic arteriovenous 
malformation had bilateral hypertensive subdural collections and slit ventricle syndrome.
Etiology Number of patients High pressure Medium pressure Low pressure
Pseudotumor cerebri 6 - 6 -
Normal pressure hydrocephalus 15 - - 15
Thalamic arteriovenous malformation 2 - 2 -
1
1
Congenital hydrocephalus 3 1 2
Postmeningitis 4 - 3
Brain tumor 2 - 1 1
Subarachnoid hemorrhage 2 - 2 -
-After traumatic brain injury 1 - 1
Total 35 1 17 18
707Fernando Campos Gomes Pinto et al. Hydrocephalus: overdrainage prevention
DISCUSSION
The main complications related to VS include: infection 
(meningitis, ventriculitis, abdominal cyst), mechanical mal-
function (system obstruction or disconnection), and overd-
rainage (subdural collections, collapsed ventricle syndrome, 
subdural hematomas). All these complications are severe, re-
quire reoperation, and may cause death2,3,7-13.
Currently, there is a consensus that, whenever possible 
and indicated, one should avoid VS implantation when a 
high complication rate is identified in the long-term (mean 
of 60 months) of up to 51% of cases; in these cases, ventricular 
neuroendoscopic procedures are given preference12,14-17.
To prevent infectious complications, the institutional 
adoption of protocols, such as first described by Choux, is 
what shows the most positive impact and control of these 
complications. Catheters impregnated with antibiotics or sil-
ver also seem to reduce infectious complications18,19.
The prevention of mechanical malfunction is related to 
good surgical technique and proper choice of the type of 
valve and the distal site of VS implant. The frontal trepana-
tion seems to be related to better positioning of the proximal 
catheter, due to puncture suitability offered by this site, as it 
accepts a wider range of introduction angles20-22.
All implanted VS have a siphon effect when the patient 
is in the orthostatic position, since there is a pressure differ-
ence between the two extremities of the system that exceeds 
the valve opening pressure. The term “siphon effect” is more 
used to describe the physical phenomenon involved, ruled by 
well-known Law of Stevin (pf=p0+d.g.h).
The term overdrainage is commonly used to describe the 
physiopathological mechanism by which an internal or ex-
ternal CSF shunt generates specific radiological or one of the 
related clinical syndromes: CSF hypotension, intracranial hy-
pertension due to the expanding effect of a hematoma, or by 
intermittent obstruction in the collapsed ventricle syndrome. 
The degree of overdrainage, and therefore the risk of clinical 
manifestations, is associated both with the intracranial pres-
sure (negative) and with the intracranial CSF volume. Patients 
with pseudotumor, for instance, may have an overdrainage 
image with normal or slightly negative intracranial pressure. 
Overdrainage is associated with compensatory intracranial 
and intraspinal hemodynamic alterations, mainly venous ones 
at first. Clinical manifestations do not always occur, which de-
pend on factors such as pre-VS brain turgor, degree of cerebral 
atrophy, pain sensitivity, and drainage speed.
To reduce overdrainage, the choice of the fixed-pressure 
valve opening pressure should be appropriate for the patient 
to ensure the necessary CSF flow to treat the hydrodynam-
ic disorder, however without causing excessive drainage and 
symptomatic intracranial hypotension2-6.
The programmable valves offer the possibility of adjust-
ment after surgery without the need for reoperation. The 
flow-regulated shunt (Orbis-sigma valve) ensures a steady flow 
and, in theory, it would better adjust to each patient, but large 
samples have not shown a superior performance of this system13.
On the other hand, the antisiphon mechanism can be im-
plemented in series with any type of valves and works by in-
creasing the resistance to flow, whenever the pressure differ-
ential (p0=ventricular - pf=distal site) increases, preventing 
overdrainage and reducing the siphon effect. A number of si-
phon regulatory devices has been developed over the past two 
decades. Basically, there are two types of antisiphon mecha-
nisms: gravity (spheres or parts that move with the force of 
gravity, hindering and reducing flow) and membrane (thin, 
flexible membrane that occludes the system when the pres-
sure difference increases due to a decrease in distal pressure)2.
Many factors can influence the dynamics of CSF drain-
age, and these can be both hydrodynamic and related to indi-
vidual physiological characteristics, which make their knowl-
edge essential when choosing the most appropriate drainage 
system for each patient and even to identify probable causes 
of hypo – or overdrainage. The main forces acting on the flow 
drained through the VS system are the intracranial pressure 
(ICP), intra-abdominal pressure (IAP), and hydrostatic pres-
sure (HP), and the correlation between these forces results in 
the perfusion pressure (PP), which can be calculated using 
the following formula: PP=HP+(ICP-IAP)5.
Large increases occur, especially in hydrostatic pressure 
gradients, when the patient sits down or stands up, causing 
excessive CSF drainage. Kajimoto et al.5 evaluated the associa-
tion between postural changes and CSF pressure in VPS sys-
tems implanted in 13 patients with hydrocephalus, with no in-
cidence of overdrainage. For that purpose, they simultaneously 
measured the pressures of the various compartments in the su-
pine and sitting positions. With the patients in the supine posi-
tion, ICP, IAP, and HP were 4.6±3, 5.7±3.3, and 3.3±1 mmHg, re-
spectively. As a result, the PP was only 2.2±4.9 mm Hg. However, 
when patients sat down, the IAP increased to 14.7±4.8 mmHg, 
and ICP decreased to – 14.2±4.5 mmHg. The increase in IAP and 
decrease in ICP compensated the HP in 67% (42.9±3.5 mmHg), 
and consequently the PP (14±6.3 mmHg) corresponded to only 
33% of HP. They demonstrated that the high IAP and low ICP 
have preventive effects and that high HP has promoting effects 
on overdrainage. In addition, they observed that only a small 
fraction of individuals with VS becomes symptomatic, due to 
the effects of CSF overdrainage5.
The gravitational antisiphon mechanism reinforces this 
protective physiological mechanism, so that the weight of the 
spheres would simulate an even greater increase in IAP. However, 
such mechanism should be implemented strictly in the vertical 
position to work properly. It has a rate of general complications 
identified in the long-term follow-up (mean of 60 months) of up 
to 21% of cases, of which 5% are related to hypodrainage12.
The individual’s physiological characteristics also make 
it difficult to determine not only the vertical level of CSF in 
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the cranial-spinal compartment, but also of the fluid level 
in the cavity where it is absorbed. Thus, it is difficult to 
precisely calculate the vertical hydrostatic difference be-
tween both compartments. Among the main physiological 
characteristics that influence the vertical hydrostatic gra-
dient are the child’s growth, increase in the compliance of 
the cranial-spinal compartment (such as spinal stenosis, 
Chiari malformation I, pseudotumor cerebri, and a large 
intracranial mass lesion). In addition, weight loss increas-
es the compliance of the peritoneal cavity ( favoring overd-
rainage), and extreme constipation can decrease intraperi-
toneal compliance (resulting in increased IAP). Therefore, 
two individuals of the same height may have differences 
in vertical hydrostatic gradient, either by a difference in 
the cranial-spinal compartment, or by one in the abdomi-
nal compartment. It is possible that overdrainage preven-
tion can be more effective with a certain antisiphon device 
than another. Moreover, even during sleep, and episodi-
cally, vasogenic brain alterations can cause an increase in 
intracranial pressure and, thus, result in overdrainage (e.g., 
Lundberg’s B waves).
These physiological characteristics may explain why 
many patients with healthy cranial-spinal compartment and 
peritoneal cavity appear to tolerate a VPS, with or without 
the use of an antisiphon mechanism, supporting the conclu-
sions of Kajimoto et al.5, whereas in other patients with al-
tered compliances hydrocephalus can be extremely difficult 
to treat through VPS (with no incidence of overdrainage), de-
spite the use of several concomitant antisiphon mechanisms.
In this study, we purposely selected patients with overd-
rainage or patients with hydrocephalus and high susceptibil-
ity to overdrainage to test the performance of the SPHERA® 
valve. The membrane antisiphon mechanism ensured ther-
apeutic success in 94.3% of the patients and showed tomo-
graphic resolution of patients with overdrainage. The only 
complication detected in this sample was infectious, not re-
lated to the functional performance of the valve.
The choice of the medium-pressure valve for pseudotu-
mor cases and low-pressure valve for NPH was adequate 
hydrodynamic to treat these hydrodynamic disorders. The 
healing process did not hinder the performance of the 
membrane antisiphon mechanism. The case of NPH, which 
showed a slight worsening in gait after the first year of im-
provement, presented no radiological signs of hypo – or 
overdrainage; it seems that the worsening was due to dis-
ease progression unrelated to hydrocephalus due to func-
tional alteration of the VS.
The membrane antisiphon mechanism has two advan-
tages. The technical advantage exists because the valve can 
be placed in any position in the skull to function properly, 
differently from the gravity mechanism, in which the verti-
cal positioning of the sphere is critical to proper operation of 
the system. Another benefit is in the antisiphon protection, 
regardless of position (supine or standing position). The anti-
siphon membrane can be used in ventricular-pleural shunts, 
in which cases the inspiratory pressure gradients, even when 
patients are lying down, can cause overdrainage.
In conclusion, the fixed-pressure valve with anti-siphon 
device SPHERA® can be used to treat patients with hydro-
cephalus and prevent overdrainage. Clinical improvement 
was observed and sustained in 94.3% of the patients for a 
two-year period, with no tomographic evidence of hypo – 
or overdrainage and no significant immediate complica-
tions, either early or late ones.
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